-
Diarylethylamine derivates methoxphenidine and its potential therapeutic benefit for the therapy of treatment resistant depression
AZV (NW24-04-00412)05/2024 – 12/2027More Info -
Novel cariprazine-derived D2/5-HT3 receptor modulators with potential impact on the treatment of schizophrenia and depressive symptoms
GAČR (24-11191O)02/2024 – 01/2027More Info -
Development of a receptor biochip for the control and regulation of steroid hormones
TAČR (FW06010206)03/2023 – 06/2026More Info -
Metabolomic and functional effects of 3α5β neuroactive steroids in perinatal brain damage
GAČR 23-05746S03/2023 – 12/2025More Info -
Alzheimer´s disease and aging: can mTOR inhibitors kill two birds with one drug?
GAČR 23-05857S01/2023 – 12/2025More Info -
The pathophysiological alterations in the brain after post-psychotic state and perinatal hypoxia
AZV (NU22J-04-00061)05/2022 – 12/2025More Info -
The role of higher sensitivity of interneurons to metabolic stress in the development of schizophrenia
GAČR (22-15096S)01/2022 – 12/2024More Info -
Role of the orbitofrontal cortex, and its modulation by endocannabinoids, in social withdrawal in schizophrenia
GAČR 22-06943S01/2022 – 12/2024More Info -
New biochip and microfluidic diagnostics of circulating biomarkers and pharmacogens in psychiatric and oncological diseases
TAČR (FW03010186)01/2021 – 12/2024More Info -
Restoration of motor function in Parkinson's disease using non-invasive hybrid transcranial neuromodulation
MŠMT (JPND-568-060)01/2021 – 12/2024More Info